<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Espersen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/markpound28/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/markpound28/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Espersen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f006802fd59fdeb866a2656dcde94b7c</guid>
				<title>Espersen posted an update: The patient was started on 40 mg/day (0.6 mg/kg/day) [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42049/</link>
				<pubDate>Sat, 08 Feb 2025 11:59:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>The patient was started on 40 mg/day (0.6 mg/kg/day) systemic isotretinoin treatment, and after two months treatment, the patient had almost complete regression of the lesions. Systemic isotretinoin is effective and easy to treat treatment for patients with multiple lesions, especially when compared to other treatments. In addition, all of the&hellip;<span class="activity-read-more" id="activity-read-more-42049"><a href="http://www.nationalboardinstitute.com/activity/p/42049/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c5198502012c85b39a8a2c8130faf1f1</guid>
				<title>Espersen posted an update: Furthermore, LPS-treated tissue cultures did not express [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40443/</link>
				<pubDate>Thu, 06 Feb 2025 16:24:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, LPS-treated tissue cultures did not express rMS-induced synaptic plasticity. Live-cell microscopy in tissue cultures prepared from a novel transgenic reporter mouse line [C57BL/6-Tg(TNFa-eGFP)] confirms that ex vivo LPS administration triggers microglial tumor necrosis factor alpha (TNFα) expression, which is ameliorated in the&hellip;<span class="activity-read-more" id="activity-read-more-40443"><a href="http://www.nationalboardinstitute.com/activity/p/40443/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c6eb357af1ad7b851dc869ba98c29d4b</guid>
				<title>Espersen posted an update: To explore the level and associated factors of perceived [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39304/</link>
				<pubDate>Wed, 05 Feb 2025 12:27:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>To explore the level and associated factors of perceived participation and autonomy among stroke survivors in Shanghai, China.</p>
<p> Cross-sectional explorative study.</p>
<p> From January to December 2018, 431 patients presenting at the neurology departments of three hospitals with a confirmed diagnosis of stroke were recruited. Impact on&hellip;<span class="activity-read-more" id="activity-read-more-39304"><a href="http://www.nationalboardinstitute.com/activity/p/39304/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">898b68e1af1c5c3cfb613f9d8955c07e</guid>
				<title>Espersen posted an update: Percutaneous coronary intervention (PCI) is well established [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37668/</link>
				<pubDate>Mon, 03 Feb 2025 11:46:14 -0800</pubDate>

									<content:encoded><![CDATA[<p>Percutaneous coronary intervention (PCI) is well established for the treatment of obstructive coronary artery disease. This study was performed to assess the impact of in-hospital mortality and 30-day readmission with intracoronary imaging as an adjunct to baseline coronary angiography.</p>
<p> The study was derived from the Healthcare Cost and&hellip;<span class="activity-read-more" id="activity-read-more-37668"><a href="http://www.nationalboardinstitute.com/activity/p/37668/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">392b4f19711f4d1cbb24092c30f4ab57</guid>
				<title>Espersen posted an update: piratory rate over 24 times per minute, HbA1c greater than [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31591/</link>
				<pubDate>Tue, 28 Jan 2025 17:07:00 -0800</pubDate>

									<content:encoded><![CDATA[<p>piratory rate over 24 times per minute, HbA1c greater than 7%, and AST higher than 40 U/L were risk factors of ICU admission for COVID-19 patients with diabetes. Investigating and monitoring these factors could assist in the risk stratification of COVID-19 patients with DM at an early stage.Ulcerative colitis (UC) is the most common inflammatory b&hellip;<span class="activity-read-more" id="activity-read-more-31591"><a href="http://www.nationalboardinstitute.com/activity/p/31591/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ae7ace664db8bd0630a36f5318cace57</guid>
				<title>Espersen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31538/</link>
				<pubDate>Tue, 28 Jan 2025 17:00:44 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>